Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.

Fuchs A, Gliwiński M, Grageda N, Spiering R, Abbas AK, Appel S, Bacchetta R, Battaglia M, Berglund D, Blazar B, Bluestone JA, Bornhäuser M, Ten Brinke A, Brusko TM, Cools N, Cuturi MC, Geissler E, Giannoukakis N, Gołab K, Hafler DA, van Ham SM, Hester J, Hippen K, Di Ianni M, Ilic N, Isaacs J, Issa F, Iwaszkiewicz-Grześ D, Jaeckel E, Joosten I, Klatzmann D, Koenen H, van Kooten C, Korsgren O, Kretschmer K, Levings M, Marek-Trzonkowska NM, Martinez-Llordella M, Miljkovic D, Mills KHG, Miranda JP, Piccirillo CA, Putnam AL, Ritter T, Roncarolo MG, Sakaguchi S, Sánchez-Ramón S, Sawitzki B, Sofronic-Milosavljevic L, Sykes M, Tang Q, Vives-Pi M, Waldmann H, Witkowski P, Wood KJ, Gregori S, Hilkens CMU, Lombardi G, Lord P, Martinez-Caceres EM, Trzonkowski P.

Front Immunol. 2018 Jan 15;8:1844. doi: 10.3389/fimmu.2017.01844. eCollection 2017.

2.

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.

Lord P, Spiering R, Aguillon JC, Anderson AE, Appel S, Benitez-Ribas D, Ten Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van Ham SM, Lattimer S, Marshall L, Harry RA, Hutchinson JA, Isaacs JD, Joosten I, van Kooten C, Lopez Diaz de Cerio A, Nikolic T, Oral HB, Sofronic-Milosavljevic L, Ritter T, Riquelme P, Thomson AW, Trucco M, Vives-Pi M, Martinez-Caceres EM, Hilkens CMU.

PeerJ. 2016 Aug 30;4:e2300. doi: 10.7717/peerj.2300. eCollection 2016.

3.

Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies.

Duggleby R, Danby RD, Madrigal JA, Saudemont A.

Front Immunol. 2018 Feb 13;9:252. doi: 10.3389/fimmu.2018.00252. eCollection 2018. Review.

4.

Targeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy.

Kim HJ, Cha GS, Joo JY, Lee J, Kim SJ, Lee J, Park SY, Choi J.

J Periodontal Implant Sci. 2017 Oct;47(5):292-311. doi: 10.5051/jpis.2017.47.5.292. Epub 2017 Oct 30.

5.

Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases.

Herkel J.

Dig Dis. 2015;33 Suppl 2:70-4. doi: 10.1159/000440750. Epub 2015 Dec 7.

PMID:
26642346
6.

Clinical application of regulatory T cells in type 1 diabetes.

Marek-Trzonkowska N, Myśliwec M, Siebert J, Trzonkowski P.

Pediatr Diabetes. 2013 Aug;14(5):322-32. doi: 10.1111/pedi.12029. Epub 2013 Apr 30. Review.

PMID:
23627860
7.

Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.

Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, Nishimura MI, Han S, Chang LJ, Atkinson MA, Ribas A, Bluestone JA.

PLoS One. 2010 Jul 22;5(7):e11726. doi: 10.1371/journal.pone.0011726.

8.

[Advances in ex vivo expansion and immunotherapy application of regulatory T cells].

Yan L, Shao ZH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Apr;23(2):562-7. doi: 10.7534/j.issn.1009-2137.2015.02.052. Chinese.

PMID:
25948225
9.

Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man.

Raker VK, Domogalla MP, Steinbrink K.

Front Immunol. 2015 Nov 9;6:569. doi: 10.3389/fimmu.2015.00569. eCollection 2015. Review.

10.

CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures.

Nowak A, Lock D, Bacher P, Hohnstein T, Vogt K, Gottfreund J, Giehr P, Polansky JK, Sawitzki B, Kaiser A, Walter J, Scheffold A.

Front Immunol. 2018 Feb 7;9:199. doi: 10.3389/fimmu.2018.00199. eCollection 2018.

11.

Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.

Gołąb K, Grose R, Trzonkowski P, Wickrema A, Tibudan M, Marek-Trzonkowska N, Matosz S, Solomina J, Ostrega D, Michael Millis J, Witkowski P.

Oncotarget. 2016 Nov 29;7(48):79474-79484. doi: 10.18632/oncotarget.13101.

12.

Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications.

Golab K, Leveson-Gower D, Wang XJ, Grzanka J, Marek-Trzonkowska N, Krzystyniak A, Millis JM, Trzonkowski P, Witkowski P.

Int Immunopharmacol. 2013 Jul;16(3):371-5. doi: 10.1016/j.intimp.2013.02.001. Epub 2013 Feb 18. Review.

PMID:
23428908
13.

Antigen-specific regulatory T cells: are police CARs the answer?

Dawson NAJ, Levings MK.

Transl Res. 2017 Sep;187:53-58. doi: 10.1016/j.trsl.2017.06.009. Epub 2017 Jun 19. Review.

PMID:
28688236
14.
15.

Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25high FOXP3+ Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy.

Wilkinson DS, Ghosh D, Nickle RA, Moorman CD, Mannie MD.

Front Immunol. 2017 Dec 14;8:1782. doi: 10.3389/fimmu.2017.01782. eCollection 2017.

16.

CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells.

Zheng J, Liu Y, Lau YL, Tu W.

Cell Mol Immunol. 2010 Jan;7(1):44-50. doi: 10.1038/cmi.2009.103.

17.

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.

Canavan JB, Scottà C, Vossenkämper A, Goldberg R, Elder MJ, Shoval I, Marks E, Stolarczyk E, Lo JW, Powell N, Fazekasova H, Irving PM, Sanderson JD, Howard JK, Yagel S, Afzali B, MacDonald TT, Hernandez-Fuentes MP, Shpigel NY, Lombardi G, Lord GM.

Gut. 2016 Apr;65(4):584-94. doi: 10.1136/gutjnl-2014-306919. Epub 2015 Feb 24.

18.

CD4+ T-regulatory cells: toward therapy for human diseases.

Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK.

Immunol Rev. 2008 Jun;223:391-421. doi: 10.1111/j.1600-065X.2008.00634.x. Review.

PMID:
18613849
19.

Human in vitro suppression as screening tool for the recognition of an early state of immune imbalance.

Waukau J, Woodliff J, Glisic S.

J Vis Exp. 2011 Jul 22;(53). pii: 3071. doi: 10.3791/3071.

20.

Supplemental Content

Support Center